PILL Fees and Costs — Direxion Daily Pharmaceutical & Medical Bull 3X Shares

Data updated: 2026-09-28

The net expense ratio is 0.97% (1.15% before fee waivers). There are no sales loads or redemption fees. In fiscal 2025 the fund paid $36K in broker commissions, 0.3095% of average net assets, and portfolio turnover was 67%.

PILL Fees and Expenses

Annual operating expenses and sales charges of PILL. Prospectus, as of February 28, 2025.

Annual operating expenses
Management fee0.75%
12b-1 fee0.00%
Other expenses0.38%
Gross expense ratio1.15%
Fee waiver−0.18%
Net expense ratio0.97%
Sales charges
Max front load—
Max deferred load—
Redemption fee—
Expense limitation in place (N-CEN)Yes
Fees waived or reduced during the yearYes
Waived fees subject to recoupmentYes

PILL Costs Over Time

On $10,000 invested in PILL, assuming 5% a year before costs, total costs come to $796 over 5 years, cutting the return by 1.34% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).

$10,000 investedSell after 1 yearSell after 3 yearsSell after 5 years
Value before costs$10,500$11,576$12,763
Fund expenses (net expense ratio 0.97%)$102$317$548
Trading costs (broker commissions)$32$101$175
Lost growth on money paid in costs$0$21$73
Total costs$134$439$796
Value after costs$10,366$11,138$11,967
Impact on return, per year1.34%1.34%1.34%

PILL Trading Costs

Brokerage costs reported on SEC Form N-CEN for the fiscal year ending October 31, 2025.

  • Explicit cost rate (commissions ÷ average net assets): 0.3095%
  • Total broker commissions: $36K
  • Bought from dealers (principal trades, not a cost): —
  • Portfolio turnover (prospectus): 67%
  • Securities on loan, average value: $280K
  • Net income from securities lending: $3K (0.026% of average net assets)

PILL Agency Brokers

Commissions paid.

BrokerAmountShare
Barclays Bank PLC$16K44.52%
Citibank, National Association$14K37.76%
UBS AG$4K11.16%
BNP Paribas$2K6.56%

For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.